Frequent Epigenetic Inactivation of Myocardin in Human Nasopharyngeal Carcinoma.

Fu Chen,Yingxi Mo,Hao Ding,Xue Xiao,Shu Yi Wang,Guangwu Huang,Zhe Zhang,Sheng Zi Wang

DOI: https://doi.org/10.1002/hed.21396

2010-01-01

Head & Neck

Abstract:Background. Epigenetic silencing of tumor suppressor genes plays an important role in nasopharyngeal carcinoma (NPC) tumorigenesis. In the present study, we explore a novel target gene of epigenetic silencing in NPC, Myocardin, which is inactivated by promoter hypermethylation.Methods. Transcriptional expression levels of Myocardin were evaluated by reverse transcription polymerase chain reaction (RT-PCR). Methylation status was addressed by methylation-specific PCR and bisulfite genomic sequencing.Results. Myocardin mRNA expression was inactivated in 4 of 5 NPC cell lines. Myocardin was aberrantly methylated in 4 of 5 NPC cell lines (80%) and in 48 of 65 NPC primary tumors (73.8%, but not in any of the 12 normal nasopharyngeal tissues tested. Myocardin expression could be reactivated in NPC cells after treatment with the demethylating agent 5-aza-2'-deoxycytidine (5-aza-dC).Conclusions. Epigenetic inactivation of Myocardin is a frequent and tumor-specific event in NPC. Our findings suggest that Myocardin is a candidate tumor suppressor gene in NPC. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 54-59, 2011